ArticleJMA journal2025

Sex Differences in Renal Outcomes and Metabolic Markers by Combination Therapy with SGLT2 Inhibitors and GLP-1 Receptor Agonists in Individuals with Type 2 Diabetes: A Post-Hoc Analysis of the RECAP Study.

Yoshimi Muta et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.